Penthrox: USA update
29 August 2018
ASX Announcement
Penthrox: USA update
Medical Developments International Limited (ASX: MVP) advise that it has received correspondence from the USA Food & Drug Administration (“FDA”) in relation to its Investigative New Drug (“IND”) application to have Penthrox approved for sale in the United States of America.
For the full release, please click on the link: Penthrox USA Update